A glycan gate controls opening of the SARS-CoV-2 spike protein
Terra Sztain, Surl-Hee Ahn, Anthony T. Bogetti, Lorenzo Casalino, Jory A. Goldsmith, E. Seitz, Ryan S. McCool, Fiona L. Kearns, F.J. Acosta-Reyes, Suvrajit Maji, Ghoncheh Mashayekhi, J. Andrew McCammon, A. Ourmazd, Joachim Frank, Jason S. McLellan, Lillian T. Chong, Rommie E. Amaro
Topics & Concepts
ChemistrySpike (software development)GlycanSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Spike ProteinBiophysicsComputational biologyVirologyNanotechnologyBiochemistryGlycoproteinManagementEconomicsInfectious disease (medical specialty)OutbreakPathologyMaterials scienceDiseaseBiologyMedicineSARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research StudiesAnimal Virus Infections Studies